Oral drug treatment helps protect cancer patients from deadly blood clots
New results from a large pilot trial run at the University’s Warwick Medical School called ‘select-d’ suggest that a daily tablet…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
GlaxoSmithKline Consumer Healthcare posts revenue of ₹ 1,180 crore in fourth quarter
Board of Directors recommends a dividend at the rate of Rs 75 per equity share for the 12 months period ended March 31, 2018
Novartis India appoints Milan Paleja as VC and MD
Paleja is a graduate from Bombay University and holds a Cost Accountants degree from the Institute of Cost Accountants of India
Glenmark Pharma gets US FDA nod for skin treatment cream
For the 12 months to March 2018, Temovate cream achieved annual sales of approximately $118 million
Zydus Cadila gets US FDA nod for Carbidopa tablets
The drug will be manufactured at the group's manufacturing facility at SEZ, Ahmedabad
Lupin launches Corcal Bone and Beauty supplement
Corcal Bone and Beauty is available in packs of 10 mini-tablets
Epygen plans to raise Rs 300 cr to propel biosimilars in India
The funds will be utlilised for clinical trials of pipeline molecules and securing IP for technologies for novel biological…
Glenmark Pharma to present updated info on GBR 830 at International Investigative Dermatology…
GBR 830 is a first-in-class, investigational, anti-OX40 monoclonal antibody for treatment of moderate-to-severe atopic dermatitis
Annual Opex in Pharma Summit to be held in Mumbai
The event will discuss on how pharma manufacturers should efficiently implement excellence initiatives
Cipla partners with MannKind for Afrezza – inhaled insulin
Signs deal for exclusive marketing and distribution of the only US FDA approved inhaled insulin
Unichem Laboatories’ Valsartan tablets receives ANDA approval
To treat hypertension, heart failure (NYHA class II – IV) and reduces cardiovascular mortality in clinically stable patients
AstraZeneca & Merck’s Lynparza tablets receive EU approval
For the treatment of platinum-sensitive relapsed ovarian cancer
Strides & Apotex agree to merge their Australian businesses
Hospital business of Apotex will not form part of the merged entity and will be retained by Apotex
Suven Life Sciences secures product patents in Australia, Eurasia and Europe
Products are being developed for cognitive disorders with high unmet medical need and with huge market potential globally
Lupin submits NDA for Etanercept biosimilar in Japan
Etanercept (YLB113) is indicated for moderate to severe Rheumatoid Arthritis (RA) and Juvenile Idiopathic Arthritis
AstraZeneca sells Seroquel rights to Luye Pharma for $538 mn
It is used for the treatment of schizophrenia and bipolar disease
iPHEX 2018 begins in New Delhi
CDSCO announces one year extension of WHO-GMP certifications
Takeda to buy Shire in a $62 billion deal
It will be the largest overseas acquisition by a Japanese company
Pharma exports show sharp turnaround; cross $17 billion
After remaining in the negative territory for the first five months of the financial year 2017-18, pharma exports have picked up…
Research team uncovers mechanism of action for pore-forming bacterial toxins
The findings could help combat associated diseases and advance crop protection